New molecule heralds hope for muscular dystrophy treatment

There's hope for patients with myotonic dystrophy, the most common form of muscular dystrophy in adults. A new small molecule has been shown to break up the protein-RNA clusters that cause the disease in living human cells, an important first step toward developing a pharmaceutical treatment for the as-yet untreatable disease.

Read the whole article on Science Daily

More from Science Daily